5. Advertising to Healthcare Professionals
5.3 Restrictions on Reprints of Journal Articles
Pharmaceutical companies may provide reprints of journal articles to healthcare professionals, subject to the conditions set forth in both laws and regulations and self-regulatory codes. Major restrictions on reprints are as follows:
- the reprint must be authorised by the author(s) under copyright law;
- the contents of the journal article shall not violate the PMD Act. In particular, the contents of the journal article shall not be false or exaggerated advertising, advertising that recommends unapproved drugs or off-label uses or advertising that slanders and/or defames competitors’ products; and
- in principle, the reprint must be related to the company’s own product and supplied in response to a request from a healthcare professional. In other words, a pharmaceutical company must refrain from actively inducing a healthcare professional to request such a reprint.